The Weizmann Institute of Science in Israel has developed a novel prostate cancer treatment called Vascular Targeted Photodynamic therapy (VTP) with TOOKAD Soluble, in collaboration with Steba Biotech.
The therapy has now been granted approval in Mexico by Cofepris, the Mexican national health authority, for the treatment of early-stage prostate cancer. The treatment includes the drug TOOKAD Soluble and a laser.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?